Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,535 | 5,167 | 7,939 | 10,276 | 27,285 |
| Marketable Securities | 8,512 | 11,113 | 11,402 | 12,610 | N/A |
| Other current assets | 77 | 0 | 0 | 0 | 67 |
| TOTAL | $14,070 | $17,214 | $20,376 | $24,183 | $27,390 |
| Non-Current Assets | |||||
| PPE Net | 11 | 14 | 19 | 25 | 30 |
| Other Non-Current Assets | 33 | 33 | 33 | 33 | 33 |
| TOTAL | $44 | $47 | $52 | $58 | $63 |
| Total Assets | $14,114 | $17,261 | $20,428 | $24,241 | $27,453 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 310 | 532 | 501 | 475 | 287 |
| Accrued Expenses | 906 | 543 | 710 | 1,216 | 1,554 |
| TOTAL | $1,614 | $1,485 | $1,617 | $2,024 | $2,103 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,614 | $1,485 | $1,617 | $2,024 | $2,103 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,545 | 26,545 | 26,545 | 26,545 | 26,545 |
| Common Shares | 265 | 265 | 265 | 265 | 265 |
| Retained earnings | -278,463 | -275,010 | -271,775 | -268,134 | -264,809 |
| TOTAL | $12,500 | $15,776 | $18,811 | $22,217 | $25,350 |
| Total Liabilities And Equity | $14,114 | $17,261 | $20,428 | $24,241 | $27,453 |